Texas Forges Ahead on Ibogaine Research Solo After Drug Company Snubs: What That Means for You

Texas is moving forward with its own $50 million ibogaine research program after failing to secure a drug company partner due to demanding state conditions. This pivot means public universities will lead the clinical trials, but a legal adjustment to Senate Bill 2308 may be required to release state funds without the initially mandated private matching investment.